Get the Stockscreener App
11.22
3.12%
0.34
After Hours:
10.78
-0.44
-3.92%
Sensei Biotherapeutics Inc stock is traded at $11.22, with a volume of 42,625.
It is up +3.12% in the last 24 hours and up +15.43% over the past month.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
See More
Previous Close:
$10.88
Open:
$10.41
24h Volume:
42,625
Relative Volume:
0.61
Market Cap:
$14.15M
Revenue:
-
Net Income/Loss:
$-29.80M
P/E Ratio:
-9.4286
EPS:
-1.19
Net Cash Flow:
$-25.19M
1W Performance:
+5.15%
1M Performance:
+15.43%
6M Performance:
+22.62%
1Y Performance:
+8.51%
1-Day Range:
$10.18
$11.35
1-Week Range:
$8.81
$11.45
52-Week Range:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Name
Sensei Biotherapeutics Inc
Sector
Industry
Phone
(240) 243-8000
Address
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
11.22 | 13.72M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-01-21 | Downgrade | Berenberg | Buy → Hold |
| Jun-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-01-21 | Initiated | Berenberg | Buy |
| Mar-01-21 | Initiated | Citigroup | Buy |
| Mar-01-21 | Initiated | Oppenheimer | Outperform |
| Mar-01-21 | Initiated | Piper Sandler | Overweight |
View All
Sensei Biotherapeutics Inc Stock (SNSE) Latest News
More than 4,600 Massachusetts biotech workers lost jobs in 2025 as industry contracts - The Business Journals
Aug Setups: Why retail investors favor Sensei Biotherapeutics Inc stock2025 Market Outlook & Verified High Yield Trade Plans - moha.gov.vn
What Makes Sensei Biotherapeutics (SNSE) a New Buy Stock - MSN
Will Sensei Biotherapeutics Inc. stock deliver shareholder valueChart Pattern Recognition & Grow Steadily With Our Wealth Roadmap - bollywoodhelpline.com
Sensei Biotherapeutics (NASDAQ:SNSE) Upgraded to “Hold” at Wall Street Zen - Defense World
Sensei Biotherapeutics Updates Executive Retention and Compensation Agreements - TipRanks
Why retail investors favor Sensei Biotherapeutics Inc. stockStock Surge & Accurate Intraday Trading Signals - DonanımHaber
Dividend Watch: Will Sensei Biotherapeutics Inc. stock deliver shareholder valueWeekly Gains Summary & Verified Momentum Watchlists - Улправда
How Sensei Biotherapeutics Inc. stock performs in rising dollar environmentEntry Point & Community Verified Swing Trade Signals - Улправда
Sensei Biotherapeutics Earnings Notes - Trefis
What Sparked Sensei Biotherapeutics (SNSE) Stock's Nearly 63% After‑Hours Jump? - Sahm
Major Stakeholders Offload Shares in Sensei Biotherapeutics! - TipRanks
Shareholder Peyer Files To Sell 841 Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Major Stakeholders Offload Sensei Biotherapeutics Shares! - TipRanks
Cambrian Biopharma Sells Shares of Sensei Biotherapeutics - TradingView — Track All Markets
Dir Peyer Sells 21,295 ($232.7K) Of Sensei Biotherapeutics Inc [SNSE] - TradingView — Track All Markets
Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 8% – What’s Next? - Defense World
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast - ts2.tech
Sensei Biotherapeutics Inc (SNSE) looking to reclaim success with recent performance - Setenews
How Sensei Biotherapeutics Inc. (4070) stock compares with tech leadersJuly 2025 Outlook & Daily Volume Surge Signals - Newser
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Can Sensei Biotherapeutics Inc. (4070) stock deliver double digit returnsWeekly Risk Summary & Capital Efficient Trading Techniques - Newser
How Sensei Biotherapeutics Inc. (4070) stock correlates with oil marketsEarnings Recap Report & Smart Money Movement Tracker - Newser
Can Sensei Biotherapeutics Inc. (4070) stock attract ESG investmentsTrade Exit Report & Low Drawdown Momentum Trade Ideas - Newser
How big funds are accumulating Sensei Biotherapeutics Inc. (4070) stockRecession Risk & Weekly High Potential Alerts - Newser
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Is Sensei Biotherapeutics Inc. stock vulnerable to regulatory risksTreasury Yields & Comprehensive Market Scan Reports - moha.gov.vn
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
Will Sensei Biotherapeutics Inc. (4070) stock outperform value peersQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com
How Sensei Biotherapeutics Inc. (4070) stock reacts to new regulations2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock deliver strong annual returnsQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock survive global slowdownTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
What sentiment indicators say about Sensei Biotherapeutics Inc. stockJuly 2025 Sector Moves & Daily Entry Point Trade Alerts - newser.com
Why Sensei Biotherapeutics Inc. (4070) stock attracts HNW investors2025 Market Trends & Weekly Market Pulse Updates - newser.com
Can Sensei Biotherapeutics Inc. (4070) stock ride next bull market cycleEarnings Risk Summary & Risk Controlled Swing Trade Alerts - newser.com
Will Sensei Biotherapeutics Inc. stock outperform Dow Jones indexFed Meeting & Daily Oversold Bounce Ideas - newser.com
Will Sensei Biotherapeutics Inc. (4070) stock announce a stock split2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
How Sensei Biotherapeutics Inc. stock reacts to inflationary pressuresMarket Performance Summary & Precise Swing Trade Alerts - newser.com
Is Sensei Biotherapeutics Inc. (4070) stock worth buying before Fed actionWeekly Investment Report & Low Drawdown Momentum Ideas - newser.com
What downside risks could hit Sensei Biotherapeutics Inc. (4070) stockTrade Exit Summary & Real-Time Buy Zone Alerts - newser.com
Sensei Biotherapeutics Inc Stock (SNSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
28.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):